FRANKLIN GENOMIC ADVANCEMENTS ETF

HELX NASDAQ Healthcare & Biotech Monde
36.49 $
1.24 %

ETF focused on companies involved in genomic advancements and genetic engineering.

Performance & Momentum

6 Months 2.78 %
1 Year 30.10 %
3 Years 16.62 %
5 Years 22.28 %

Similar stocks to FRANKLIN GENOMIC ADVANCEMENTS ETF

Anantys Community

Be the first to share your analysis on FRANKLIN GENOMIC ADVANCEMENTS ETF .

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases